About Edifice Health

Edifice Health provides the Inflammatory Age® test, a biomarker composite scoring system developed from a decade-long NIH-funded study, to measure and monitor systemic chronic inflammation. This technology enables healthcare providers to identify and manage chronic inflammation, which is linked to age-related diseases and overall health deterioration.

```xml <problem> Systemic chronic inflammation is a root cause of many age-related diseases and overall health deterioration, but it is difficult to measure and monitor effectively with traditional methods. This lack of precise monitoring hinders proactive management and early detection of inflammation-related health issues. </problem> <solution> Edifice Health offers the Inflammatory Age® test, a biomarker composite scoring system derived from a decade-long NIH-funded study, to quantify and track systemic chronic inflammation. Using advanced 'omics' platforms and artificial intelligence, the test provides insights into an individual's inflammatory and immune health. The Inflammatory Age® metric predicts multi-morbidity, immune function, and cumulative physiological damage, offering previously unattainable insights into biological health. By partnering with clinics and physicians, Edifice Health aims to facilitate early detection and prevention of disease through proactive management of chronic inflammation. </solution> <features> - Biomarker composite scoring system for measuring systemic chronic inflammation - Derived from a 10-year NIH-funded longitudinal research study (Stanford 1,000 Immunomes Project) - Utilizes state-of-the-art 'omics' platforms and advanced artificial intelligence methods - Provides an Inflammatory Age® metric that predicts multi-morbidity, immune function, and cumulative physiological damage </features> <target_audience> The primary target audience includes healthcare providers focusing on early detection and prevention of disease, as well as individuals interested in proactively managing their inflammatory health for better overall health and longevity. </target_audience> ```

What does Edifice Health do?

Where is Edifice Health located?

Edifice Health is based in San Mateo, Philippines.

When was Edifice Health founded?

Edifice Health was founded in 2018.

How much funding has Edifice Health raised?

Edifice Health has raised $15.7M.

Who founded Edifice Health?

Edifice Health was founded by David Furman.

David Furman - Founder/CSO

Location

San Mateo, Philippines

Founded

2018

Funding

$15.7M

Employees

5 employees

Investors

Ahren Innovation Capital Betterfood Ventures Etpvc

Edifice Health

San Mateo, PhilippinesFounded 20185700+ followers7/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.

Updated 18 months ago

Funding

$15.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Systemic chronic inflammation is a root cause of many age-related diseases and overall health deterioration, but it is difficult to measure and monitor effectively with traditional methods. This lack of precise monitoring hinders proactive management and early detection of inflammation-related health issues.

Solution

Edifice Health offers the Inflammatory Age® test, a biomarker composite scoring system derived from a decade-long NIH-funded study, to quantify and track systemic chronic inflammation. Using advanced 'omics' platforms and artificial intelligence, the test provides insights into an individual's inflammatory and immune health. The Inflammatory Age® metric predicts multi-morbidity, immune function, and cumulative physiological damage, offering previously unattainable insights into biological health. By partnering with clinics and physicians, Edifice Health aims to facilitate early detection and prevention of disease through proactive management of chronic inflammation.

Target Audience

The primary target audience includes healthcare providers focusing on early detection and prevention of disease, as well as individuals interested in proactively managing their inflammatory health for better overall health and longevity.

Features

Biomarker composite scoring system for measuring systemic chronic inflammation
Derived from a 10-year NIH-funded longitudinal research study (Stanford 1,000 Immunomes Project)
Utilizes state-of-the-art 'omics' platforms and advanced artificial intelligence methods
Provides an Inflammatory Age® metric that predicts multi-morbidity, immune function, and cumulative physiological damage